Vernalis plc

Overview

• Industrybiotechnology, pharmaceutical industry¹
• HeadquartersWinnersh¹
• Legal formpublic limited company¹
• LEI2138004C6IRJ5KXAHX81³
• StatusActive³
• LEI statusLapsed (not renewed)³
• Registered address100 BERKSHIRE PLACE, RG41 5RD Winnersh, United Kingdom³
• Registered withCompanies House, 02304992³

See how the biggest companies compare on our leaderboards

Vernalis plc was a UK-based pharmaceuticals business headquartered in Winnersh, with research in Cambridge, and with a Berwyn, PA, US-based commercial operation, Vernalis Therapeutics Inc., focusing on the sales and marketing of slow-release formulations of prescription cough and cold medicines. Tuzistra XR (codeine polistirex/ chlorpheniramine polistirex) was the first launched product which arose from this strategy, however sales did not reach expectations.²

Leadership

Who has led Vernalis plc, and when. Pick a name to see everywhere that person has worked.

• Chief executive officerIan R. Garland 2008 to 2018¹
• Chief executive officerSimon J. Sturge 2003 to 2008¹
• ChairPeter J. Fellner 2003 to 2018¹

Employees over time

• 201875¹

Timeline

1. 2008New chief executive Ian R. Garland becomes CEO¹
2. 2003New chief executive Simon J. Sturge becomes CEO¹
3. 2003Founded Founded¹

Links

• WikipediaVernalis plc
• WikidataQ59580617